(1641-1)
Anti-Smad2 antibody [EP567Y] (ab33875)
Overview
- Product nameAnti-Smad2 antibody [EP567Y]See all Smad2 primary antibodies ...
- DescriptionRabbit monoclonal [EP567Y] to Smad2
- SpecificityThis antibody detects a region about 40AA before the MH2 region(not the MH2 region itself)
- Tested applicationsWB, IHC-P, ICC, Flow Cyt more details
- Species reactivityReacts with: Mouse, Rat, Human
- Immunogen
A synthetic peptide corresponding to residues surrounding the MH2 domain of human Smad2.
- Positive controlJurkat cell lysate and human adenocarcinoma of uterus
- General notesProduced under U.S. Patent No. 5,675,063.
Properties
- FormLiquid
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
- Storage bufferPBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
-
Concentration information loading... - Clonality Monoclonal
- Clone numberEP567Y
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab33875 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: 1/1000. Detects a band of approximately 58 kDa (predicted molecular weight: 58 kDa). |
| IHC-P | IHC-P: Use at an assay dependent dilution. |
| ICC | ICC: 1/250 - 1/500. |
| Flow Cyt | Flow Cyt: 1/20 - 1/100. |
Target
- FunctionReceptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma.
- Tissue specificityExpressed at high levels in skeletal muscle, heart and placenta.
- Sequence similaritiesBelongs to the dwarfin/SMAD family.
Contains 1 MH1 (MAD homology 1) domain.
Contains 1 MH2 (MAD homology 2) domain. - Post-translational
modificationsPhosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases. Able to interact with SMURF2 when phosphorylated on Ser-465/467, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, phosphorylated on Ser-240 by CaMK2. Phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin.
In response to TGF-beta, ubiquitinated by NEDD4L; which promotes its degradation.
Acetylated on Lys-19 by coactivators in response to TGF-beta signaling, which increases transcriptional activity. Isoform short: Acetylation increases DNA binding activity in vitro and enhances its association with target promoters in vivo. Acetylation in the nucleus by EP300 is enhanced by TGF-beta. - Cellular localizationCytoplasm. Nucleus. Cytoplasmic and nuclear in the absence of TGF-beta. On TGF-beta stimulation, migrates to the nucleus when complexed with SMAD4. On dephosphorylation by phosphatase PPM1A, released from the SMAD2/SMAD4 complex, and exported out of the nucleus by interaction with RANBP1.
-
Database links
- Entrez Gene: 4087 Human
- Entrez Gene: 17126 Mouse
- Entrez Gene: 29357 Rat
- Omim: 601366 Human
- SwissProt: Q15796 Human
- SwissProt: Q62432 Mouse
- SwissProt: O70436 Rat
- Unigene: 12253 Human
- Unigene: 705764 Human
- Unigene: 391091 Mouse
- Unigene: 2755 Rat
see all
Target information above from: UniProt accession
Q15796
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- hMAD 2 antibodyhMAD-2 antibodyhSMAD2 antibody
- JV18 1 antibodyJV18 antibodyJV18 antibodyJV18-1 antibodyJV181 antibodyMAD antibodyMAD antibodyMAD homolog 2 antibodyMAD Related Protein 2 antibodyMad-related protein 2 antibodyMADH2 antibodyMADR2 antibodyMGC22139 antibodyMGC34440 antibodyMothers Against Decapentaplegic Homolog 2 antibodyMothers Against Decapentaplegic Homolog 2 antibodymothers against DPP homolog 2 antibodyOTTHUMP00000163489 antibodySma and Mad related protein 2 antibodySMAD 2 antibodySMAD antibodySMAD family member 2 antibodySMAD, mothers against DPP homolog 2 antibodySMAD2 antibodySMAD2_HUMAN antibody
see all
Anti-Smad2 antibody [EP567Y] images
-
Anti-Smad2 antibody [EP567Y] (ab33875) at 1/1000 dilution + Jurkat cell lysate
Predicted band size : 58 kDa
Observed band size : 58 kDa -
ab33875, at a 1/50 dilution,staining human adenocarcinoma of uterus by Immunohistochemistry, Paraffin embedded tissue.
-
All lanes : Anti-Smad2 antibody [EP567Y] (ab33875) at 1/3000 dilution
Lane 1 : HGL-5 cells - no additives
Lane 2 : Cells + activin A
Lane 3 : Cells + cyclophilin siRNA Control
Lane 4 : Cells + activin A + cyclophilin
Lane 5 : non-targeting, negative control for siRNA
Lane 6 : Cells + activin A, negative control for siRNA
Lane 7 : Cells + siRNA Smartpool
Lane 8 : Cells + activin A + siRNA Smartpool
Lane 9 : Jurkat cells
Secondary
Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP) (ab6721) at 1/50000 dilution
Performed under reducing conditions.
Predicted band size : 58 kDa
Observed band size : 58 kDaThis image is courtesy of an Abreview submitted by Mrs Birte Jablonski
-
Overlay histogram showing PC3 cells stained with ab33875 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab33875, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a decreased signal in PC3 cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
References for Anti-Smad2 antibody [EP567Y] (ab33875)
This product has been referenced in:
- Zieba A et al. Intercellular variation in signaling through the TGF-ß pathway and its relation to cell density and cell cycle phase. Mol Cell Proteomics 11:M111.013482 (2012). Read more (PubMed: 22442258) »
- Guillory B et al. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer. Am J Pathol 177:2635-44 (2010). IHC-P ; Mouse . Read more (PubMed: 20847285) »
![Western blot - Smad2 antibody [EP567Y] (ab33875) Western blot - Smad2 antibody [EP567Y] (ab33875)](http://a.abcam.com/ps/datasheet/Images/33/ab33875/ab33875_1.jpg)
![Flow Cytometry - Smad2 antibody [EP567Y] (ab33875) Flow Cytometry - Smad2 antibody [EP567Y] (ab33875)](http://a.abcam.com/ps/datasheet/images/33/ab33875/Smad2-Primary-antibodies-ab33875-1.jpg)